will the weight loss industry experience a boom in 2024?

The future of weight loss drugs

Just now the weight loss drug market did not develop that much. With the insurance not covering costs and unknown side effects there is still very much that needs to be researched and tested. Companies like Eli Lilly or Novo Nordisk now experience big supply issues. How will the companies face these issues and who will lead the weight loss drug-market in the future?

The biggest weight loss drug companies right now

Right now the two biggest player of the weight loss industry are Eli Lilly and Novo Nordisk. These two are competing against each other with drugs for diabetes or obesity. Even thought the Eli Lilly weight loss drugs seem to be more effective than these from Novo Nordisk. And not just that. Eli Lilly also seems to be better of with the financing. The company has much more diversified sources of income so it won’t go bankrupt if one source just goes bust.

Other companies in the industry are UnitedHealth Group, Johnson & Johnson, and Merck. These are the five biggest companies in the industry and they are competing to be leading in not just the weight loss drug industry but in other future developments as well that might cure other diseases.

The five candidates are also the most valuable in the industry. There are discussions about if one of the companies might reach the $1 trillion valuation in the future. The most valuable company of all five is Eli Lilly. It has a market cap of $610 billion. Second off is UnitedHealth Group with roughly $482 billion followed by the Denmark-based drug maker Novo Nordisk with a market cap of $470 billion. Fourth in the list is Johnson & Johnson. The company is worth about $390 billion. Last up is Merck with a valuation of $300 billion.

What are the leading drugs in the industry?

Some of the most effective and most common weight loss drugs come from Eli Lilly or Novo Nordisk but also other companies like Johnson & Johnson.

Eli Lilly for example manufactures drugs like Zepbound. The new weight loss drug helped people lose a tremendous amount of weight. Some people reported a loss of 52 pounds (23.6 kg) in just 16 months. The drug shares the ingredient tirzepatide which is also used in Eli Lilly’s popular diabetes medication “Mounjaro”.

Nova Nordisk made pills like Wegovy which people can use for long-term weight management. It is only for adults just like the majority of the other pills. Clinical trails show that up to 87% of those that take the pill lost at least 10% of their body weight. A study even showed an average of 13.4% in just a year. That study also differed between people with and without diabetes. Theses without even reached a rate of 17% but these with diabetes only lost 10% body weight.

Johnson & Johnson developed a drug called Invokana. This drug is used for patients that have diabetes and helps those to lose weight. According to studies does the drug combines with older med phentermine delivered a 7.5% loss of body weight.

Side effects of these weight loss drugs

There are a lot of possible side effects. This means you should really think twice before taking these drugs. These side effects can be not as bad but some really might have a big influence on your body. The main side effects are Urinary tract infections, increased urinary frequency, hypotension, hypoglycemic disorder, vulvovaginal candidiasis, nausea, diarrhea, vomiting, constipation, and stomach pain. Please talk to your doctor before taking these pills and try to lose weight naturally.


latest posts:

VW struggles with profitability and the circumstances are getting worse.
blog | economics | news economics

Volkswagens problems with profitability

Volkswagen experiences big problems all around the company, especially with profitability and what to do next. To face these issues the board of directors planned to lay off some employees….

New requirements for ING customers
blog | economics | news economics

ING will increase fees for customers

Many people thought that since the interest rate in Germany and Europe is high, the fees for bank accounts might be low. As it turns out, they are very wrong….

Recent challenges at Intel
blog | economics

The Challenging Situation at Intel

Intel is facing significant challenges due to delays in advancing its manufacturing processes and increasing competition from AMD, NVIDIA, and TSMC. The company’s internal leadership issues have also contributed to its struggles, leading to financial losses and reduced market share. To address these issues, Intel is investing in advanced manufacturing, strategic partnerships, and organizational changes.

Leave a Reply